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EMPLOYMENT OPPORTUNITIES
Pre- and Postdoctoral Positions in Statistical Genetic
Analysis and Genetic Epidemiology.—The Genetics of
Complex Disorders (GCD) training program in the De-
partment of Psychiatry at Columbia University provides
pre- and postdoctoral training in the genetic epidemi-
ology and statistical genetic analysis of complex diseases,
including psychiatric disorders. Our mission is to train
scientists who will be aware of all aspects of genetic
studies, including study design, clinical aspects, pheno-
type definition, molecular laboratory issues, and statis-
tical analysis. Training includes both didactic compo-
nents (coursework and lab rotations) and research. We
seek applicants with training in statistics, epidemiol-
ogy, and/or genetics and with demonstrated interest in
pursuing a career in the genetic analysis of complex
disorders. Applicants for postdoctoral positions must
have a Ph.D., an M.D., or the equivalent; predoctoral
applicants need a master’s degree. Further information
can be obtained from our Web site (http://cpmcnet
.columbia.edu/dept/sph/epi/gcd/) or from the following
mailing address: Susan E. Hodge, D.Sc., NYSPI, Unit
24, 1051 Riverside Drive, New York, NY 10032. Co-
lumbia University is an affirmative action/equal oppor-
tunity employer. Applicants must be U.S. citizens or per-
manent resident aliens.
Project Scientist.—A research position is available im-
mediately at the Cleveland Clinic Foundation (CCF)
Center for Cardiovascular Genetics and Department of
Molecular Cardiology and at the Cleveland Clinic Col-
lege of Medicine at Case Western Reserve University.
The CCF cardiovascular medicine program is one of the
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largest such programs in the United States and has been
consistently ranked first for the past 10 years by U.S.
News and World Report. We use cutting-edge technol-
ogies to clone and functionally characterize genes for
various cardiovascular diseases. State-of-the-art research
facilities are available for these projects. The CCF Cen-
ter for Cardiovascular Genetics is directed by Dr. Qing
Wang, who has been a key researcher involved in dis-
covering three genes for long QT syndrome, the first gene
for Brugada syndrome, the first gene for Klippel-Tren-
aunay syndrome, and the first nonlipid-related disease-
causing gene for coronary artery disease and myocardial
infarction. We are recruiting an experienced scientist to
expand our research programs into either the molecular
genetics of heart failure or stem-cell biology in cardio-
vascular medicine. Applicants with experience in the ge-
netics of heart failure or stem-cell biology are preferred.
Interested applicants should submit a curriculum vitae
and the names of and contact information for three ref-
erences to Dr. Qing Wang, Center for Cardiovascular
Genetics, ND40, Lerner Research Institute, The Cleve-
land Clinic Foundation, 9500 Euclid Avenue, Cleveland,
OH 44195; fax: (216) 445-4990; e-mail: wangq2@ccf
.org. For more information about our projects, please
visit our Web site (http://www.lerner.ccf.org/moleccard/
wang/).
SAMPLES AVAILABLE
Positive Control Samples for Molecular Genetic Test-
ing.—The Centers for Disease Control and Prevention
and the Coriell Institute for Medical Research announce
the availability of positive control samples derived from
transformed cell lines for use in molecular genetic test-
ing. The DNA samples prepared from these validated
cell lines are available through the Coriell Cell Reposi-
tories (http://ccr.coriell.org/cdc/). Diseases include cys-
tic fibrosis (CF), 5,10-methylenetetrahydrofolate reduc-
tase (MTHFR) deficiency, HFE-associated hereditary
hemochromatosis, Huntington disease (HD), fragile X
syndrome, Muenke syndrome, connexin 26–associated
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deafness, and a-thalassemia. These validated cell lines
contain mutations of public-health importance, some
of which were not previously available. The CF samples
contain mutations associated with unique populations
(394delTT and S1235R), combinations of IVS8 poly-
thymidine tract variants (5T, 7T, and 9T), and muta
tions not previously available (I148T and 1078delT).
Three DNA samples with homozygous MTHFR-related
mutations (A222V/A222V) are available. Hemochro-
matosis-associated samples include a compound HFE
heterozygote (H63D/S65C) as well as other combina-
tions of HFE alleles. DNA samples with triplet repeats
at the intermediate range are available for study of HD
(31 repeats) and fragile X syndrome (56 repeats). Mu-
tations were confirmed by reference testing and multil-
aboratory pilot testing in all cell lines from which the
DNA has been prepared. Control DNA samples that
are negative for all mutations are also available. Infor-
mation about ordering these samples can be obtained
from the Web catalog (http://ccr.coriell.org/cdc/comm/
order/order.html). Further information can be obtained
from Jeanne C. Beck, Ph.D., Coriell Institute for Medical
Research, Coriell Cell Repositories, 403 Haddon Ave-
nue, Camden, NJ 08103.
DATABASE AVAILABLE
CEPH Genotype Database, Version 10.—The Founda-
tion Jean Dausset–Centre dEtude du Polymorphisme
Humain (CEPH) has released version 10 of the CEPH
Genotype Database (http://www.cephb.fr/cephdb/). The
database contains genotypes for 32,356 DNA markers
that have been accumulated since 1985 for 874 individ-
uals from 65 CEPH reference families (Genomics [1990]
6:575–577). Included in the database are genotypes for
21,480 biallelic markers, of which 17,512 are identified
in dbSNP by rs or ss numbers. The database contains
genotypes for 19,900 microsatellite markers. The mean
observed heterozygote frequency is 0.438 for all the loci
in version 10 and 0.698 for identifiable microsatellites,
of which 56% are highly polymorphic (observed het-
erozygote frequency 0.70). The CEPH database now
manages 6,081,570 genotypes. A total of 25,924,717
LOD scores have been computed between all pairs of
syntenic loci. Each of 32,023 markers is assigned to a
chromosome by linkage or other means. Genotypes may
be downloaded by marker ID, chromosome, family, and
observed heterozygote frequency. In addition to geno-
types by family, downloadable information includes al-
lele frequencies, lists of close (linked) markers, and
graphically represented pedigrees with genotypes. Ver-
sion 10 links to the National Center for Biotechnology
Information (NCBI) Entrez Web site, allowing entry into
the current build of dbSNP and other NCBI databases.
CEPH collaborators and others who have genotyped
CEPH reference families can submit data for markers
directly through the CEPH Web server. Marker submis-
sions require a submitter password, which is available
by e-mail request (cephdbm@cephb.fr). File submission
is also available after consultation with CEPH.
